Trials / Sponsors / CND Life Sciences
CND Life Sciences
Academic / Other · 8 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essentia Essential Tremor, Movement Disorders, Essential Tremor, Essential Tremor-plus | — | 2026-02-18 |
| Recruiting | Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behav PARKINSON DISEASE (Disorder), Parkinson, Parkinson s Disease | — | 2025-11-04 |
| Recruiting | Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis PARKINSON DISEASE (Disorder), Parkinson, Parkinson's Disease and Parkinsonism | — | 2025-09-03 |
| Active Not Recruiting | Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson REM Behavior Disorder, Parkinson Disease | — | 2024-12-17 |
| Active Not Recruiting | Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project Long COVID-19, Acute COVID-19, Postural Orthostatic Tachycardia Syndrome (POTS) | — | 2023-11-30 |
| Active Not Recruiting | The Syn-Sleep Study REM Sleep Behavior Disorder (iRBD) | — | 2022-09-15 |
| Active Not Recruiting | A Diagnostic Test for Dementia With Lewy Bodies MCI-AD, Early Stage Alzheimer's Disease, MCI-DLB, Early Stage Dementia With Lewy Bodies | — | 2022-08-15 |
| Completed | Synuclein-One Study Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies | — | 2021-01-04 |